Mizuho Cuts Acadia Healthcare (NASDAQ:ACHC) Price Target to $17.00

Acadia Healthcare (NASDAQ:ACHC) had its price target decreased by Mizuho from $22.00 to $17.00 in a research report report published on Thursday, Marketbeat.com reports. Mizuho currently has a neutral rating on the stock.

Several other research firms have also recently commented on ACHC. Royal Bank Of Canada dropped their target price on shares of Acadia Healthcare from $22.00 to $19.00 and set an “outperform” rating for the company in a research report on Wednesday, December 3rd. Leerink Partners restated a “market perform” rating and set a $14.00 price target (down from $25.00) on shares of Acadia Healthcare in a research report on Wednesday, December 3rd. Guggenheim reduced their price target on Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating on the stock in a research note on Monday, November 10th. Raymond James Financial set a $17.00 price objective on Acadia Healthcare in a research report on Wednesday, December 3rd. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, October 8th. Eight analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $22.75.

Acadia Healthcare Trading Down 0.1%

NASDAQ ACHC opened at $14.41 on Thursday. The stock has a market cap of $1.33 billion, a P/E ratio of 12.32, a price-to-earnings-growth ratio of 3.55 and a beta of 0.91. Acadia Healthcare has a fifty-two week low of $12.63 and a fifty-two week high of $47.08. The stock has a 50 day simple moving average of $18.40 and a two-hundred day simple moving average of $21.10. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.44 and a current ratio of 1.44.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.01. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.The firm had revenue of $851.57 million for the quarter, compared to analysts’ expectations of $852.43 million. During the same period in the previous year, the firm earned $0.91 earnings per share. The business’s revenue was up 4.4% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. On average, analysts forecast that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Wellington Management Group LLP increased its position in shares of Acadia Healthcare by 11.8% during the third quarter. Wellington Management Group LLP now owns 9,423,548 shares of the company’s stock valued at $233,327,000 after acquiring an additional 993,205 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of Acadia Healthcare by 7.8% in the third quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company’s stock worth $233,166,000 after purchasing an additional 681,278 shares during the last quarter. Abrams Bison Investments LLC lifted its holdings in shares of Acadia Healthcare by 22.3% during the third quarter. Abrams Bison Investments LLC now owns 4,380,000 shares of the company’s stock valued at $108,449,000 after purchasing an additional 800,000 shares in the last quarter. UBS Group AG boosted its position in shares of Acadia Healthcare by 8.8% during the third quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock valued at $107,377,000 after buying an additional 350,484 shares during the last quarter. Finally, State Street Corp raised its position in Acadia Healthcare by 3.2% in the 2nd quarter. State Street Corp now owns 3,095,775 shares of the company’s stock worth $70,243,000 after buying an additional 95,670 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.